Press Сentre
Наши новости
On May 30th, the ceremonial rewarding of winners and prizers of 17th Scientific and Practical Conference “Start into innovations” who received grants from the Physical-engineering Lyceum’s development foundation was held in Pyotr Kapitsa Physical-engineering Lyceum.
Many projects were carried out under scientific guidance of scientists from ...
05.06.2018
IPHARMA of ChemRar Group participated in 10th DIA China Annual Meeting, which was held on May 23–25, 2018, and gathered more than 2,000 professionals from various countries and fields of pharmaceutical R&D industry to discuss changes in innovation segment and regulatory system of Chinese healthcare.
PRC’s pharmaceutical market is top second ...
01.06.2018
In 2016–17 BioIntegrator conducted a big surveillance program to approve safety profile of domestic drug Nescler (INN Fingolimod) for Russian patients suffering remitting multiple sclerosis.
The program confirmed a favorable safety profile of Nescler that was comparable to the original product, Gilenia.
Results of the ...
16.05.2018
On April 18, 2018, an extended board meeting of Russian Ministry of Industry and Trade was held featuring Deputy Prime Ministers of Russian Government – Dmitry Rogozin, Arkady Dvorkovich, Olga Golodets, as well as other members of the Russian Government. At this meeting, Denis Manturov, Minister of Industry and Trade, reported on the Ministry’s ...
23.04.2018
During April and May 2018, experts and leaders of the ChemRar Group will conduct a series of workshops on various business topics at the Moscow Institute of Physics and Technology as a part of the Business for Dummies educational course. Although the course was created for the students of Innovative Pharmaceutics, Medical Technology and ...
03.04.2018
ChemRar Group took part in the first pharmaceutical subgroup joint meeting of the Russian-Italian task force on industrial development and high-tech solutions, which was held in Milan on March 19–20, 2018. At the meeting, Russia was presented by a substantial delegation of executives of Russian pharmaceutical enterprises including APS Tecnologies ...
26.03.2018
The “ChemRar Center for Development of Innovative and Import-substituting Drugs” project was approved in 2009 by the Presidential Commission for Modernisation and Technological Development of Russia’s Economy. It included the following activities:
Designing a technological platform for finished dosage forms development and trial production of ...
06.03.2018
Russian innovative infrastructure, science and business leaders gathered at the third Congress of NeuroNet Industrial Union, which was held on February 3rd, 2018 at ASI’s Boiling point. The main goal of the event was to define the further development vector for NeuroNet market to help Russian companies win leading positions in global labor ...
08.02.2018
The winners of the sixth annual National Rating of Russian High-Tech Rapidly Developing Companies TechUspekh-2017, organized by RVC together with PwC, the Association of Innovative Regions of Russia and the National Research University Higher School of Economics, were announced on December 12, 2017. Data for more than one hundred domestic ...
21.12.2017
The Award Ceremony for the domestic pharmaceutical and medical industry institutional awards of the Ministry of Industry and Trade of the Russian Federation was held at the opening ceremony of the Russian Health Care Week 2017 on December 4, 2017. Irina Tyrnova, who has headed Viriom since its founding in 2009, and under whose supervision ELPIDA® ...
08.12.2017
In early November, IPHARMA, a company of ChemRar Group, received two approvals from the Ministry of Healthcare of the Russian Federation to conduct phase I clinical trials of Ventvil® and Slavinorm®.
Protocol No. HEP-VTL-01 “A double-blind, randomized, placebo-controlled trial of the safety and tolerability of increasing doses of Ventvil® in ...
17.11.2017
On November 14–16, the 21st Russian Oncology Congress was held in Moscow. It is the largest international event in the field of oncology, which is attended by over 5,000 doctors annually.
The permanent organizers of the Congress: N.N. Blokhin Russian Cancer Research Center and the Russian Society of Clinical Oncology under the aegis of the ...
16.11.2017
Публикации в печатных и электронных СМИ
Видео
Фото
